Projects per year
Personal profile
Education
- 2010 PhD, Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
Experience
- 2010/8-2011/7 Postdotoral research fellow, College of Pharmacy, University of Michigan, Ann Arbor, MI University of Michigan, Michigan, USA
- 2011/08 ~ 2012/07 Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, South Dakota State University, USA
- 2012/08 ~ 2017/01 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
- 2017/02~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
Research Interests
- Pharmacoeconomics
- Patient-reported outcomes
- Pharmacoepidemiology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Huang-Tz Ou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 8 Finished
-
-
-
建構創新糖尿病疾病預測與成本效益模型,以提供台灣於疾病照護與健保政策之參酌:應用機器學習與模型方法於臨床大數據之研究
19-08-01 → 20-07-31
Project: Research project
-
-
-
Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach
Yang, C. T., Chong, K. S., Wang, C. C., Ou, H. T. & Kuo, S., 2024 Dec, In: Cardiovascular Diabetology. 23, 1, 244.Research output: Contribution to journal › Article › peer-review
Open Access -
Kidney outcomes with SGLT2is for type 2 diabetes patients: does background treatment with metformin or RASis matter?
Chong, K. S., Chang, Y. H., Lin, M. H., Hsu, C. N., Wang, C. C., Wang, C. Y., Huang, Y. L., Lin, F. J. & Ou, H. T., 2024, In: Frontiers in Endocrinology. 15, 1329945.Research output: Contribution to journal › Article › peer-review
Open Access -
Longitudinal economic burden of incident complications among metabolic syndrome populations
Chong, K. S., Chang, Y. H., Yang, C. T., Chou, C. K., Ou, HT. & Kuo, S., 2024 Dec, In: Cardiovascular Diabetology. 23, 1, 246.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan
Cheng, H. J., Weng, S. H., Wu, J. L., Yeh, S. T., Chen, H. F., Novida, H., Ou, H-T. & Li, C. Y., 2024 Jul 1, In: Annals of Family Medicine. 22, 4, p. 309-316 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework
Yang, C. T., Yao, W. Y., Yang, C. Y., Peng, Z. Y., Ou, H. T. & Kuo, S., 2024 Mar, In: Journal of Internal Medicine. 295, 3, p. 357-368 12 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus)